Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'

Dani receiving his award from ISPE
Dani (second from right) with his ISPE award recognising his contribution to COVID-19 research

The award was presented at the 38th International Conference on Pharmacoepidemiology, which took place in Copenhagen, in recognition of Dani's demonstrable impact on public health related to the COVID-19 pandemic through his work in Pharmacoepidemiology.

Daniel is the Professor of Pharmaco- and Device Epidemiology and Section Head for Health Data Sciences at the Botnar Research Centre, NDORMS, University of Oxford.

As a member of the European Health Data & Evidence Network (EHDEN) and the Observational Health Data Sciences and Informatics (OHDSI), Dani has studied the impacts and effects of COVID-19 throughout the pandemic to better inform the global response.

Projects included:

  • Projects exploring the risks and efficacy of the COVID-19 vaccines, including the impact on neurological disorders;
  • An international study to understand the characteristics of patients suffering from COVID-19 in greater detail;
  • Research to understand the safety profile and risks of Hydroxychloroquine, that was considered a potential COVID-19 treatment;
  • And hosting a COVID-19 virtual study-a-thon to inform healthcare decision-making in response to the global pandemic.

Commenting on the award Daniel said: "All senior awards recognise the work of many, not one individual. This one in particular acknowledges the work of my team at the Botnar Research Centre (University of Oxford), Erasmus MC Rotterdam, and colleagues in the EHDEN and OHDSI communities who went the extra mile for months. We rallied to generate actionable evidence on the impact of COVID-19, and for the monitoring of COVID vaccine safety."